Hanseatic Management Services Inc Incyte Corp Transaction History

Hanseatic Management Services Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 29, 2020	SELL	$85.07 - $109.69 $636,919 - $821,249	-7,487 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$74.18 - $108.93 $555,385 - $815,558	7,487 New	7,487 $778,000
Q2 2019 Jul 19, 2019	SELL	$73.52 - $88.7 $1.14 Million - $1.37 Million	-15,465 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$63.56 - $88.17 $982,955 - $1.36 Million	15,465 New	15,465 $1.33 Million
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $20,863 - $26,001	-223 Closed	0 $0
Q3 2017 Nov 07, 2017	SELL	$109.15 - $138.27 $840,564 - $1.06 Million	-7,701 Reduced 97.19%	223 $26,000
Q2 2017 Aug 11, 2017	BUY	N/A	7,924	7,924 $998,000

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

Stay updated on Hanseatic Management Services Inc with notifications on news.